Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $345

HCA Holdings, Inc. +0.13%

HCA Holdings, Inc.

HCA

322.16

+0.13%

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE: HCA) with a Outperform and raises the price target from $330 to $345.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via